+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Bipolar Disorder Therapeutics Market by Drug Class, Therapy Type, Disease Phase, Distribution Channel, Route Of Administration, Patient Age Group, Disorder Type - Global Forecast 2025-2030- Product Image
Bipolar Disorder Therapeutics Market by Drug Class, Therapy Type, Disease Phase, Distribution Channel, Route Of Administration, Patient Age Group, Disorder Type - Global Forecast 2025-2030- Product Image
Sale

Bipolar Disorder Therapeutics Market by Drug Class, Therapy Type, Disease Phase, Distribution Channel, Route Of Administration, Patient Age Group, Disorder Type - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 181 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 6010914
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The bipolar disorder therapeutics market is rapidly evolving, driven by advances in genomics, digital health integration, and shifting regulatory landscapes. Senior industry leaders face a dynamic environment where clinical innovation, differentiated care models, and global supply chain pressures converge to create distinct market opportunities and competitive challenges.

Market Snapshot: Bipolar Disorder Therapeutics

The Bipolar Disorder Therapeutics Market grew from USD 6.37 billion in 2024 to USD 6.72 billion in 2025. It is expected to continue growing at a CAGR of 5.39%, reaching USD 8.73 billion by 2030. Sustained expansion is propelled by the adoption of new treatment modalities, the integration of precision medicine, and increasingly patient-centric care delivery models. The market’s trajectory is shaped by technological breakthroughs, supply chain recalibrations, and a highly segmented competitive arena responding to varied demographic needs.

Scope & Segmentation

This report delivers actionable insights across the full scope of the bipolar disorder therapeutics market, supporting strategic decisions from portfolio development to regional expansion:

  • Drug Classes: Antidepressants (including SNRIs, SSRIs, and TCAs), Atypical Antipsychotics (such as aripiprazole, olanzapine, quetiapine, risperidone), Mood Stabilizers (carbamazepine, lamotrigine, lithium, valproate)
  • Therapy Types: Combination therapies (e.g., antipsychotic with antidepressant, mood stabilizer with antidepressant or antipsychotic) and monotherapy approaches
  • Disease Phases: Acute treatment and maintenance therapy
  • Distribution Channels: Hospital pharmacy, online pharmacy, retail pharmacy
  • Routes of Administration: Injectable and oral formulations
  • Patient Age Groups: Adult, geriatric, pediatric
  • Disorder Types: Bipolar I, bipolar II, cyclothymia, mixed episode, rapid cycling
  • Geographies: Americas (including U.S., Canada, Mexico, Brazil, Argentina), Europe, Middle East & Africa (including major and emerging markets), Asia-Pacific (including China, India, Japan, Australia, and additional regional economies)
  • Technologies: Pharmacogenomics, artificial intelligence, digital mood monitoring, telepsychiatry platforms
  • Competitive Landscape: Comprehensive review of leading multinational pharmaceutical companies and innovative biotechnology entrants

Key Takeaways for Decision-Makers

  • Personalized treatment approaches are gaining traction, supported by advances in genetic profiling and real-world data analytics.
  • Digital health solutions—particularly telepsychiatry and mood monitoring platforms—are redefining patient engagement and supporting therapy adherence.
  • Shifts in clinical strategies favor integrated care models, leveraging pharmacological and nonpharmacological interventions to improve quality of life and achieve sustained remission.
  • Competitive differentiation is increasingly influenced by patient support programs and value-based contracting, alongside robust product pipelines.
  • Collaborative partnerships among pharmaceutical leaders, biotech firms, and health systems are accelerating access to next-generation therapies.
  • Segment-specific dynamics—from formulation preferences to distribution networks—shape local market success and unlock growth opportunities across regions.

Tariff Impact on Supply Chains and Pricing

Recent U.S. tariff regulations have heightened supply chain complexity, affecting raw material costs and prompting a shift toward domestic and nearshore sourcing strategies. These changes have resulted in more intricate procurement and logistics operations, raising the importance of supply chain resilience and advanced forecasting systems. Downstream, payers now scrutinize total therapy costs more closely, influencing manufacturing and distribution strategies across the market. Smaller biotechnology firms may face increased hurdles in clinical development and market entry during ongoing tariff pressures.

Methodology & Data Sources

This report employs a rigorous, multi-method research approach, integrating extensive secondary research from peer-reviewed journals, regulatory documents, and clinical guidelines with primary insights from expert interviews and site visits. Quantitative validation, data triangulation, and quality control protocols ensure that findings are robust and reliable, offering a solid foundation for strategic planning.

Bipolar Disorder Therapeutics Market: Why This Report Matters

  • Enables senior leaders to benchmark strategies by mapping innovation pipelines and identifying emerging patient care models in bipolar disorder therapeutics.
  • Supports market entry and positioning with up-to-date intelligence on regulatory shifts, competitive actions, and regional adoption trends.
  • Delivers actionable segmentation and technology insights essential for resource allocation, R&D investment, and scaling resilient operations.

Conclusion

The bipolar disorder therapeutics sector is defined by accelerating clinical and technological advancements, nuanced market segmentation, and shifting regulatory landscapes. Organizations equipped with targeted, patient-centric strategies are well-positioned to drive long-term growth and deliver measurable improvements in patient outcomes.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Integration of digital cognitive behavioral therapy platforms with pharmacological management for bipolar depression
5.2. Development of glutamatergic modulators as rapid acting treatments for acute bipolar depressive episodes
5.3. Advances in long acting injectable antipsychotic formulations to improve adherence in bipolar disorder patients
5.4. Implementation of artificial intelligence based predictive analytics for early detection of bipolar disorder relapse
5.5. Emerging biomarker guided precision medicine approaches to tailor mood stabilizer therapy in bipolar patients
5.6. Utilization of smartphone monitoring apps for real world evidence on mood variability and treatment outcomes
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Bipolar Disorder Therapeutics Market, by Drug Class
8.1. Introduction
8.2. Antidepressants
8.2.1. SNRIs
8.2.2. SSRIs
8.2.3. TCAs
8.3. Atypical Antipsychotics
8.3.1. Aripiprazole
8.3.2. Olanzapine
8.3.3. Quetiapine
8.3.4. Risperidone
8.4. Mood Stabilizers
8.4.1. Carbamazepine
8.4.2. Lamotrigine
8.4.3. Lithium
8.4.4. Valproate
9. Bipolar Disorder Therapeutics Market, by Therapy Type
9.1. Introduction
9.2. Combination Therapy
9.2.1. Atypical Antipsychotic And Antidepressant
9.2.2. Mood Stabilizer And Antidepressant
9.2.3. Mood Stabilizer And Atypical Antipsychotic
9.3. Monotherapy
10. Bipolar Disorder Therapeutics Market, by Disease Phase
10.1. Introduction
10.2. Acute Treatment
10.3. Maintenance Therapy
11. Bipolar Disorder Therapeutics Market, by Distribution Channel
11.1. Introduction
11.2. Hospital Pharmacy
11.3. Online Pharmacy
11.4. Retail Pharmacy
12. Bipolar Disorder Therapeutics Market, by Route Of Administration
12.1. Introduction
12.2. Injectable
12.3. Oral
13. Bipolar Disorder Therapeutics Market, by Patient Age Group
13.1. Introduction
13.2. Adult
13.3. Geriatric
13.4. Pediatric
14. Bipolar Disorder Therapeutics Market, by Disorder Type
14.1. Introduction
14.2. Bipolar I
14.3. Bipolar II
14.4. Cyclothymia
14.5. Mixed Episode
14.6. Rapid Cycling
15. Americas Bipolar Disorder Therapeutics Market
15.1. Introduction
15.2. United States
15.3. Canada
15.4. Mexico
15.5. Brazil
15.6. Argentina
16. Europe, Middle East & Africa Bipolar Disorder Therapeutics Market
16.1. Introduction
16.2. United Kingdom
16.3. Germany
16.4. France
16.5. Russia
16.6. Italy
16.7. Spain
16.8. United Arab Emirates
16.9. Saudi Arabia
16.10. South Africa
16.11. Denmark
16.12. Netherlands
16.13. Qatar
16.14. Finland
16.15. Sweden
16.16. Nigeria
16.17. Egypt
16.18. Turkey
16.19. Israel
16.20. Norway
16.21. Poland
16.22. Switzerland
17. Asia-Pacific Bipolar Disorder Therapeutics Market
17.1. Introduction
17.2. China
17.3. India
17.4. Japan
17.5. Australia
17.6. South Korea
17.7. Indonesia
17.8. Thailand
17.9. Philippines
17.10. Malaysia
17.11. Singapore
17.12. Vietnam
17.13. Taiwan
18. Competitive Landscape
18.1. Market Share Analysis, 2024
18.2. FPNV Positioning Matrix, 2024
18.3. Competitive Analysis
18.3.1. Otsuka Pharmaceutical Co., Ltd.
18.3.2. AstraZeneca PLC
18.3.3. AbbVie Inc.
18.3.4. Johnson & Johnson
18.3.5. Sumitomo Dainippon Pharma Co., Ltd.
18.3.6. Eli Lilly and Company
18.3.7. GlaxoSmithKline plc
18.3.8. Merck & Co., Inc.
18.3.9. Novartis AG
18.3.10. H. Lundbeck A/S
19. ResearchAI
20. ResearchStatistics
21. ResearchContacts
22. ResearchArticles
23. Appendix
List of Figures
FIGURE 1. BIPOLAR DISORDER THERAPEUTICS MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2024 VS 2030 (%)
FIGURE 6. GLOBAL BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY THERAPY TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY THERAPY TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY DISEASE PHASE, 2024 VS 2030 (%)
FIGURE 10. GLOBAL BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY DISEASE PHASE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 12. GLOBAL BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2030 (%)
FIGURE 14. GLOBAL BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY PATIENT AGE GROUP, 2024 VS 2030 (%)
FIGURE 16. GLOBAL BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY PATIENT AGE GROUP, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. GLOBAL BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY DISORDER TYPE, 2024 VS 2030 (%)
FIGURE 18. GLOBAL BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY DISORDER TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. AMERICAS BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. AMERICAS BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. UNITED STATES BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 22. UNITED STATES BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. EUROPE, MIDDLE EAST & AFRICA BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. EUROPE, MIDDLE EAST & AFRICA BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. ASIA-PACIFIC BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 26. ASIA-PACIFIC BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 27. BIPOLAR DISORDER THERAPEUTICS MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 28. BIPOLAR DISORDER THERAPEUTICS MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 29. BIPOLAR DISORDER THERAPEUTICS MARKET: RESEARCHAI
FIGURE 30. BIPOLAR DISORDER THERAPEUTICS MARKET: RESEARCHSTATISTICS
FIGURE 31. BIPOLAR DISORDER THERAPEUTICS MARKET: RESEARCHCONTACTS
FIGURE 32. BIPOLAR DISORDER THERAPEUTICS MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. BIPOLAR DISORDER THERAPEUTICS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY ANTIDEPRESSANTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY ANTIDEPRESSANTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY SNRIS, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY SNRIS, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY SSRIS, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY SSRIS, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY TCAS, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY TCAS, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY ANTIDEPRESSANTS, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY ANTIDEPRESSANTS, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY ATYPICAL ANTIPSYCHOTICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY ATYPICAL ANTIPSYCHOTICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY ARIPIPRAZOLE, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY ARIPIPRAZOLE, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY OLANZAPINE, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY OLANZAPINE, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY QUETIAPINE, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY QUETIAPINE, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY RISPERIDONE, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY RISPERIDONE, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY ATYPICAL ANTIPSYCHOTICS, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY ATYPICAL ANTIPSYCHOTICS, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY MOOD STABILIZERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY MOOD STABILIZERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY CARBAMAZEPINE, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY CARBAMAZEPINE, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY LAMOTRIGINE, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY LAMOTRIGINE, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY LITHIUM, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY LITHIUM, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY VALPROATE, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY VALPROATE, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY MOOD STABILIZERS, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY MOOD STABILIZERS, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY THERAPY TYPE, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY THERAPY TYPE, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY COMBINATION THERAPY, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY COMBINATION THERAPY, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY ATYPICAL ANTIPSYCHOTIC AND ANTIDEPRESSANT, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY ATYPICAL ANTIPSYCHOTIC AND ANTIDEPRESSANT, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY MOOD STABILIZER AND ANTIDEPRESSANT, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY MOOD STABILIZER AND ANTIDEPRESSANT, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY MOOD STABILIZER AND ATYPICAL ANTIPSYCHOTIC, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY MOOD STABILIZER AND ATYPICAL ANTIPSYCHOTIC, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY COMBINATION THERAPY, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY COMBINATION THERAPY, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY MONOTHERAPY, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY MONOTHERAPY, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY DISEASE PHASE, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY DISEASE PHASE, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY ACUTE TREATMENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY ACUTE TREATMENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY MAINTENANCE THERAPY, BY REGION, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY MAINTENANCE THERAPY, BY REGION, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 75. GLOBAL BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY INJECTABLE, BY REGION, 2018-2024 (USD MILLION)
TABLE 76. GLOBAL BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY INJECTABLE, BY REGION, 2025-2030 (USD MILLION)
TABLE 77. GLOBAL BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY ORAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 78. GLOBAL BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY ORAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 79. GLOBAL BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 80. GLOBAL BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 81. GLOBAL BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY ADULT, BY REGION, 2018-2024 (USD MILLION)
TABLE 82. GLOBAL BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY ADULT, BY REGION, 2025-2030 (USD MILLION)
TABLE 83. GLOBAL BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY GERIATRIC, BY REGION, 2018-2024 (USD MILLION)
TABLE 84. GLOBAL BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY GERIATRIC, BY REGION, 2025-2030 (USD MILLION)
TABLE 85. GLOBAL BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY PEDIATRIC, BY REGION, 2018-2024 (USD MILLION)
TABLE 86. GLOBAL BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY PEDIATRIC, BY REGION, 2025-2030 (USD MILLION)
TABLE 87. GLOBAL BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY DISORDER TYPE, 2018-2024 (USD MILLION)
TABLE 88. GLOBAL BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY DISORDER TYPE, 2025-2030 (USD MILLION)
TABLE 89. GLOBAL BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY BIPOLAR I, BY REGION, 2018-2024 (USD MILLION)
TABLE 90. GLOBAL BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY BIPOLAR I, BY REGION, 2025-2030 (USD MILLION)
TABLE 91. GLOBAL BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY BIPOLAR II, BY REGION, 2018-2024 (USD MILLION)
TABLE 92. GLOBAL BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY BIPOLAR II, BY REGION, 2025-2030 (USD MILLION)
TABLE 93. GLOBAL BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY CYCLOTHYMIA, BY REGION, 2018-2024 (USD MILLION)
TABLE 94. GLOBAL BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY CYCLOTHYMIA, BY REGION, 2025-2030 (USD MILLION)
TABLE 95. GLOBAL BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY MIXED EPISODE, BY REGION, 2018-2024 (USD MILLION)
TABLE 96. GLOBAL BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY MIXED EPISODE, BY REGION, 2025-2030 (USD MILLION)
TABLE 97. GLOBAL BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY RAPID CYCLING, BY REGION, 2018-2024 (USD MILLION)
TABLE 98. GLOBAL BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY RAPID CYCLING, BY REGION, 2025-2030 (USD MILLION)
TABLE 99. AMERICAS BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 100. AMERICAS BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 101. AMERICAS BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY ANTIDEPRESSANTS, 2018-2024 (USD MILLION)
TABLE 102. AMERICAS BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY ANTIDEPRESSANTS, 2025-2030 (USD MILLION)
TABLE 103. AMERICAS BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY ATYPICAL ANTIPSYCHOTICS, 2018-2024 (USD MILLION)
TABLE 104. AMERICAS BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY ATYPICAL ANTIPSYCHOTICS, 2025-2030 (USD MILLION)
TABLE 105. AMERICAS BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY MOOD STABILIZERS, 2018-2024 (USD MILLION)
TABLE 106. AMERICAS BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY MOOD STABILIZERS, 2025-2030 (USD MILLION)
TABLE 107. AMERICAS BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY THERAPY TYPE, 2018-2024 (USD MILLION)
TABLE 108. AMERICAS BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY THERAPY TYPE, 2025-2030 (USD MILLION)
TABLE 109. AMERICAS BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY COMBINATION THERAPY, 2018-2024 (USD MILLION)
TABLE 110. AMERICAS BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY COMBINATION THERAPY, 2025-2030 (USD MILLION)
TABLE 111. AMERICAS BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY DISEASE PHASE, 2018-2024 (USD MILLION)
TABLE 112. AMERICAS BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY DISEASE PHASE, 2025-2030 (USD MILLION)
TABLE 113. AMERICAS BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 114. AMERICAS BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 115. AMERICAS BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 116. AMERICAS BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 117. AMERICAS BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 118. AMERICAS BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 119. AMERICAS BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY DISORDER TYPE, 2018-2024 (USD MILLION)
TABLE 120. AMERICAS BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY DISORDER TYPE, 2025-2030 (USD MILLION)
TABLE 121. AMERICAS BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 122. AMERICAS BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 123. UNITED STATES BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 124. UNITED STATES BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 125. UNITED STATES BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY ANTIDEPRESSANTS, 2018-2024 (USD MILLION)
TABLE 126. UNITED STATES BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY ANTIDEPRESSANTS, 2025-2030 (USD MILLION)
TABLE 127. UNITED STATES BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY ATYPICAL ANTIPSYCHOTICS, 2018-2024 (USD MILLION)
TABLE 128. UNITED STATES BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY ATYPICAL ANTIPSYCHOTICS, 2025-2030 (USD MILLION)
TABLE 129. UNITED STATES BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY MOOD STABILIZERS, 2018-2024 (USD MILLION)
TABLE 130. UNITED STATES BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY MOOD STABILIZERS, 2025-2030 (USD MILLION)
TABLE 131. UNITED STATES BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY THERAPY TYPE, 2018-2024 (USD MILLION)
TABLE 132. UNITED STATES BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY THERAPY TYPE, 2025-2030 (USD MILLION)
TABLE 133. UNITED STATES BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY COMBINATION THERAPY, 2018-2024 (USD MILLION)
TABLE 134. UNITED STATES BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY COMBINATION THERAPY, 2025-2030 (USD MILLION)
TABLE 135. UNITED STATES BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY DISEASE PHASE, 2018-2024 (USD MILLION)
TABLE 136. UNITED STATES BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY DISEASE PHASE, 2025-2030 (USD MILLION)
TABLE 137. UNITED STATES BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 138. UNITED STATES BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 139. UNITED STATES BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 140. UNITED STATES BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 141. UNITED STATES BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 142. UNITED STATES BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 143. UNITED STATES BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY DISORDER TYPE, 2018-2024 (USD MILLION)
TABLE 144. UNITED STATES BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY DISORDER TYPE, 2025-2030 (USD MILLION)
TABLE 145. UNITED STATES BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 146. UNITED STATES BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 147. CANADA BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 148. CANADA BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 149. CANADA BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY ANTIDEPRESSANTS, 2018-2024 (USD MILLION)
TABLE 150. CANADA BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY ANTIDEPRESSANTS, 2025-2030 (USD MILLION)
TABLE 151. CANADA BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY ATYPICAL ANTIPSYCHOTICS, 2018-2024 (USD MILLION)
TABLE 152. CANADA BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY ATYPICAL ANTIPSYCHOTICS, 2025-2030 (USD MILLION)
TABLE 153. CANADA BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY MOOD STABILIZERS, 2018-2024 (USD MILLION)
TABLE 154. CANADA BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY MOOD STABILIZERS, 2025-2030 (USD MILLION)
TABLE 155. CANADA BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY THERAPY TYPE, 2018-2024 (USD MILLION)
TABLE 156. CANADA BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY THERAPY TYPE, 2025-2030 (USD MILLION)
TABLE 157. CANADA BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY COMBINATION THERAPY, 2018-2024 (USD MILLION)
TABLE 158. CANADA BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY COMBINATION THERAPY, 2025-2030 (USD MILLION)
TABLE 159. CANADA BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY DISEASE PHASE, 2018-2024 (USD MILLION)
TABLE 160. CANADA BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY DISEASE PHASE, 2025-2030 (USD MILLION)
TABLE 161. CANADA BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 162. CANADA BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 163. CANADA BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 164. CANADA BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 165. CANADA BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 166. CANADA BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 167. CANADA BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY DISORDER TYPE, 2018-2024 (USD MILLION)
TABLE 168. CANADA BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY DISORDER TYPE, 2025-2030 (USD MILLION)
TABLE 169. MEXICO BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 170. MEXICO BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 171. MEXICO BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY ANTIDEPRESSANTS, 2018-2024 (USD MILLION)
TABLE 172. MEXICO BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY ANTIDEPRESSANTS, 2025-2030 (USD MILLION)
TABLE 173. MEXICO BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY ATYPICAL ANTIPSYCHOTICS, 2018-2024 (USD MILLION)
TABLE 174. MEXICO BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY ATYPICAL ANTIPSYCHOTICS, 2025-2030 (USD MILLION)
TABLE 175. MEXICO BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY MOOD STABILIZERS, 2018-2024 (USD MILLION)
TABLE 176. MEXICO BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY MOOD STABILIZERS, 2025-2030 (USD MILLION)
TABLE 177. MEXICO BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY THERAPY TYPE, 2018-2024 (USD MILLION)
TABLE 178. MEXICO BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY THERAPY TYPE, 2025-2030 (USD MILLION)
TABLE 179. MEXICO BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY COMBINATION THERAPY, 2018-2024 (USD MILLION)
TABLE 180. MEXICO BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY COMBINATION THERAPY, 2025-2030 (USD MILLION)
TABLE 181. MEXICO BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY DISEASE PHASE, 2018-2024 (USD MILLION)
TABLE 182. MEXICO BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY DISEASE PHASE, 2025-2030 (USD MILLION)
TABLE 183. MEXICO BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 184. MEXICO BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 185. MEXICO BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 186. MEXICO BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 187. MEXICO BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 188. MEXICO BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 189. MEXICO BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY DISORDER TYPE, 2018-2024 (USD MILLION)
TABLE 190. MEXICO BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY DISORDER TYPE, 2025-2030 (USD MILLION)
TABLE 191. BRAZIL BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 192. BRAZIL BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 193. BRAZIL BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY ANTIDEPRESSANTS, 2018-2024 (USD MILLION)
TABLE 194. BRAZIL BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY ANTIDEPRESSANTS, 2025-2030 (USD MILLION)
TABLE 195. BRAZIL BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY ATYPICAL ANTIPSYCHOTICS, 2018-2024 (USD MILLION)
TABLE 196. BRAZIL BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY ATYPICAL ANTIPSYCHOTICS, 2025-2030 (USD MILLION)
TABLE 197. BRAZIL BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY MOOD STABILIZERS, 2018-2024 (USD MILLION)
TABLE 198. BRAZIL BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY MOOD STABILIZERS, 2025-2030 (USD MILLION)
TABLE 199. BRAZIL BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY THERAPY TYPE, 2018-2024 (USD MILLION)
TABLE 200. BRAZIL BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY THERAPY TYPE, 2025-2030 (USD MILLION)
TABLE 201. BRAZIL BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY COMBINATION THERAPY, 2018-2024 (USD MILLION)
TABLE 202. BRAZIL BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY COMBINATION THERAPY, 2025-2030 (USD MILLION)
TABLE 203. BRAZIL BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY DISEASE PHASE, 2018-2024 (USD MILLION)
TABLE 204. BRAZIL BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY DISEASE PHASE, 2025-2030 (USD MILLION)
TABLE 205. BRAZIL BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 206. BRAZIL BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 207. BRAZIL BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 208. BRAZIL BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 209. BRAZIL BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 210. BRAZIL BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 211. BRAZIL BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY DISORDER TYPE, 2018-2024 (USD MILLION)
TABLE 212. BRAZIL BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY DISORDER TYPE, 2025-2030 (USD MILLION)
TABLE 213. ARGENTINA BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 214. ARGENTINA BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 215. ARGENTINA BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY ANTIDEPRESSANTS, 2018-2024 (USD MILLION)
TABLE 216. ARGENTINA BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY ANTIDEPRESSANTS, 2025-2030 (USD MILLION)
TABLE 217. ARGENTINA BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY ATYPICAL ANTIPSYCHOTICS, 2018-2024 (USD MILLION)
TABLE 218. ARGENTINA BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY ATYPICAL ANTIPSYCHOTICS, 2025-2030 (USD MILLION)
TABLE 219. ARGENTINA BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY MOOD STABILIZERS, 2018-2024 (USD MILLION)
TABLE 220. ARGENTINA BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY MOOD STABILIZERS, 2025-2030 (USD MILLION)
TABLE 221. ARGENTINA BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY THERAPY TYPE, 2018-2024 (USD MILLION)
TABLE 222. ARGENTINA BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY THERAPY TYPE, 2025-2030 (USD MILLION)
TABLE 223. ARGENTINA BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY COMBINATION THERAPY, 2018-2024 (USD MILLION)
TABLE 224. ARGENTINA BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY COMBINATION THERAPY, 2025-2030 (USD MILLION)
TABLE 225. ARGENTINA BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY DISEASE PHASE, 2018-2024 (USD MILLION)
TABLE 226. ARGENTINA BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY DISEASE PHASE, 2025-2030 (USD MILLION)
TABLE 227. ARGENTINA BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 228. ARGENTINA BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 229. ARGENTINA BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 230. ARGENTINA BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 231. ARGENTINA BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 232. ARGENTINA BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 233. ARGENTINA BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY DISORDER TYPE, 2018-2024 (USD MILLION)
TABLE 234. ARGENTINA BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY DISORDER TYPE, 2025-2030 (USD MILLION)
TABLE 235. EUROPE, MIDDLE EAST & AFRICA BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 236. EUROPE, MIDDLE EAST & AFRICA BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 237. EUROPE, MIDDLE EAST & AFRICA BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY ANTIDEPRESSANTS, 2018-2024 (USD MILLION)
TABLE 238. EUROPE, MIDDLE EAST & AFRICA BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY ANTIDEPRESSANTS, 2025-2030 (USD MILLION)
TABLE 239. EUROPE, MIDDLE EAST & AFRICA BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY ATYPICAL ANTIPSYCHOTICS, 2018-2024 (USD MILLION)
TABLE 240. EUROPE, MIDDLE EAST & AFRICA BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY ATYPICAL ANTIPSYCHOTICS, 2025-2030 (USD MILLION)
TABLE 241. EUROPE, MIDDLE EAST & AFRICA BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY MOOD STABILIZERS, 2018-2024 (USD MILLION)
TABLE 242. EUROPE, MIDDLE EAST & AFRICA BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY MOOD STABILIZERS, 2025-2030 (USD MILLION)
TABLE 243. EUROPE, MIDDLE EAST & AFRICA BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY THERAPY TYPE, 2018-2024 (USD MILLION)
TABLE 244. EUROPE, MIDDLE EAST & AFRICA BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY THERAPY TYPE, 2025-2030 (USD MILLION)
TABLE 245. EUROPE, MIDDLE EAST & AFRICA BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY COMBINATION THERAPY, 2018-2024 (USD MILLION)
TABLE 246. EUROPE, MIDDLE EAST & AFRICA BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY COMBINATION THERAPY, 2025-2030 (USD MILLION)
TABLE 247. EUROPE, MIDDLE EAST & AFRICA BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY DISEASE PHASE, 2018-2024 (USD MILLION)
TABLE 248. EUROPE, MIDDLE EAST & AFRICA BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY DISEASE PHASE, 2025-2030 (USD MILLION)
TABLE 249. EUROPE, MIDDLE EAST & AFRICA BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 250. EUROPE, MIDDLE EAST & AFRICA BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 251. EUROPE, MIDDLE EAST & AFRICA BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 252. EUROPE, MIDDLE EAST & AFRICA BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 253. EUROPE, MIDDLE EAST & AFRICA BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 254. EUROPE, MIDDLE EAST & AFRICA BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 255. EUROPE, MIDDLE EAST & AFRICA BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY DISORDER TYPE, 2018-2024 (USD MILLION)
TABLE 256. EUROPE, MIDDLE EAST & AFRICA BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY DISORDER TYPE, 2025-2030 (USD MILLION)
TABLE 257. EUROPE, MIDDLE EAST & AFRICA BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 258. EUROPE, MIDDLE EAST & AFRICA BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 259. UNITED KINGDOM BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 260. UNITED KINGDOM BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 261. UNITED KINGDOM BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY ANTIDEPRESSANTS, 2018-2024 (USD MILLION)
TABLE 262. UNITED KINGDOM BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY ANTIDEPRESSANTS, 2025-2030 (USD MILLION)
TABLE 263. UNITED KINGDOM BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY ATYPICAL ANTIPSYCHOTICS, 2018-2024 (USD MILLION)
TABLE 264. UNITED KINGDOM BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY ATYPICAL ANTIPSYCHOTICS, 2025-2030 (USD MILLION)
TABLE 265. UNITED KINGDOM BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY MOOD STABILIZERS, 2018-2024 (USD MILLION)
TABLE 266. UNITED KINGDOM BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY MOOD STABILIZERS, 2025-2030 (USD MILLION)
TABLE 267. UNITED KINGDOM BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY THERAPY TYPE, 2018-2024 (USD MILLION)
TABLE 268. UNITED KINGDOM BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY THERAPY TYPE, 2025-2030 (USD MILLION)
TABLE 269. UNITED KINGDOM BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY COMBINATION THERAPY, 2018-2024 (USD MILLION)
TABLE 270. UNITED KINGDOM BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY COMBINATION THERAPY, 2025-2030 (USD MILLION)
TABLE 271. UNITED KINGDOM BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY DISEASE PHASE, 2018-2024 (USD MILLION)
TABLE 272. UNITED KINGDOM BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY DISEASE PHASE, 2025-2030 (USD MILLION)
TABLE 273. UNITED KINGDOM BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 274. UNITED KINGDOM BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 275. UNITED KINGDOM BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 276. UNITED KINGDOM BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 277. UNITED KINGDOM BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 278. UNITED KINGDOM BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 279. UNITED KINGDOM BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY DISORDER TYPE, 2018-2024 (USD MILLION)
TABLE 280. UNITED KINGDOM BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY DISORDER TYPE, 2025-2030 (USD MILLION)
TABLE 281. GERMANY BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 282. GERMANY BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 283. GERMANY BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY ANTIDEPRESSANTS, 2018-2024 (USD MILLION)
TABLE 284. GERMANY BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY ANTIDEPRESSANTS, 2025-2030 (USD MILLION)
TABLE 285. GERMANY BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY ATYPICAL ANTIPSYCHOTICS, 2018-2024 (USD MILLION)
TABLE 286. GERMANY BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY ATYPICAL ANTIPSYCHOTICS, 2025-2030 (USD MILLION)
TABLE 287. GERMANY BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY MOOD STABILIZERS, 2018-2024 (USD MILLION)
TABLE 288. GERMANY BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY MOOD STABILIZERS, 2025-2030 (USD MILLION)
TABLE 289. GERMANY BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY THERAPY TYPE, 2018-2024 (USD MILLION)
TABLE 290. GERMANY BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY THERAPY TYPE, 2025-2030 (USD MILLION)
TABLE 291. GERMANY BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY COMBINATION THERAPY, 2018-2024 (USD MILLION)
TABLE 292. GERMANY BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY COMBINATION THERAPY, 2025-2030 (USD MILLION)
TABLE 293. GERMANY BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY DISEASE PHASE, 2018-2024 (USD MILLION)
TABLE 294. GERMANY BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY DISEASE PHASE, 2025-2030 (USD MILLION)
TABLE 295. GERMANY BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 296. GERMANY BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 297. GERMANY BIP

Samples

Loading
LOADING...

Companies Mentioned

The major companies profiled in this Bipolar Disorder Therapeutics market report include:
  • Otsuka Pharmaceutical Co., Ltd.
  • AstraZeneca PLC
  • AbbVie Inc.
  • Johnson & Johnson
  • Sumitomo Dainippon Pharma Co., Ltd.
  • Eli Lilly and Company
  • GlaxoSmithKline plc
  • Merck & Co., Inc.
  • Novartis AG
  • H. Lundbeck A/S

Table Information

Report AttributeDetails
No. of Pages181
PublishedAugust 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 6.72 Billion
Forecasted Market Value ( USD ) by 2030 $ 8.73 Billion
Compound Annual Growth Rate5.3%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Bipolar Disorder Therapeutics - Global Strategic Business Report - Product Image

Bipolar Disorder Therapeutics - Global Strategic Business Report

  • Report
  • 380 Pages
  • Global
From
Bipolar Disorder Therapeutics Market Report 2025 - Product Image

Bipolar Disorder Therapeutics Market Report 2025

  • Report
  • 200 Pages
  • Global
From
Bipolar Disorder Treatment - Global Strategic Business Report - Product Image

Bipolar Disorder Treatment - Global Strategic Business Report

  • Report
  • 387 Pages
  • Global
From
Bipolar Disorder (Manic Depression)- Pipeline Insight, 2025 - Product Image

Bipolar Disorder (Manic Depression)- Pipeline Insight, 2025

  • Clinical Trials
  • 80 Pages
  • Global
From
Bipolar Depression - Pipeline Insight, 2025 - Product Image

Bipolar Depression - Pipeline Insight, 2025

  • Clinical Trials
  • 60 Pages
  • Global
From

About the Bipolar Disorder Drug Market

The Bipolar Disorder Drug market is a subset of the Mental Disorders Drugs market, which includes medications used to treat a variety of mental health conditions. Bipolar Disorder Drugs are used to treat the symptoms of bipolar disorder, a mental health condition characterized by extreme shifts in mood, energy, and activity levels. These drugs are typically prescribed to help manage the manic and depressive episodes associated with the disorder. Commonly prescribed Bipolar Disorder Drugs include mood stabilizers, antipsychotics, and antidepressants. The Bipolar Disorder Drug market is highly competitive, with a range of pharmaceutical companies offering products to treat the condition. Some of the major players in the market include Eli Lilly, Pfizer, GlaxoSmithKline, AstraZeneca, and Novartis. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.